Adnoc L&S Surges 40 Percent in Revenue and Unveils $3 Billion Expansion Plan for 2029
Adnoc L&S, a subsidiary of Abu Dhabi National Oil Company, has announced a bold $3 billion increase in capital expenditure, aimed at boosting capacity through 2029—exclusive of its previously disclosed projects. This strategic move underscores an aggressive post-IPO investment drive.
Second-quarter financials reveal revenue of $1.25 billion, marking a 40% year-over-year jump, while net profit climbed 14% to $236 million. For the first half of 2025, cumulative revenue hit $2.43 billion, also up 40%, with net profit rising to $420 million—a 5% increase over last year.
CEO Abdulkareem Al Masabi credited the company’s diversified strengths in logistics, shipping, and services for the robust results. Recent years have seen Adnoc L&S acquire leading offshore and tanker companies, with the latest being the complete takeover of Navig8 Group. The company is also ramping up investments in new shipbuilding, especially in gas carriers.
Al Masabi highlighted disciplined financial management, keeping net debt/EBITDA between 2.0 and 2.5, and credited strong cash flow and strategic partnerships for exceeding market expectations. On the back of these results, Adnoc L&S has raised its full-year revenue growth forecast to the upper end of 20% and expects net profit to grow in the low-to-mid double digits.
2026-08-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Japan Extends Bisphenol A Anti-Dumping Probe, Prolonging Uncertainty for Korean and Taiwanese Suppliers
-
Kemira to Acquire Water Engineering for USD 150 Million
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
Sumitomo Chemical Launches Pilot Plant for Ethanol-to-Propylene Process
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
China’s Acrylic Emulsion Leaders Raise Prices by Up to 15% as Monomer Costs Surge
-
U.S. 10% Temporary Tariff Expires, New Section 301 Tariffs Not Yet Implemented
-
“Zero Tariff Is Not a Get-Out-of-Jail-Free Card”: Hainan’s Full Customs Closure—Boon or Trap for the Chemical Industry?
Recommend Reading
-
BASF Raises European NPG and HDO Prices by Up to €300/Tonne as Costs Climb
-
Kemira Acquires AquaBlue
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 13, 2026: Volatile
-
Premium Global Chemical Sourcing Requests (28 Feb - 3 Mar, 2026)
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
-
Concerns Over Raw Material Supply Spill Over, Plastic Sector Surges
-
Geopolitical Conflicts Reignite, Why Lithium Carbonate Has Not Shown the Same Frenzy as 4 Years Ago in China